Amicogen, Inc. logo — company profile

Amicogen, Inc.

Founded 2000 21 employees Post-IPO Equity Total: $6.00B Biotechnology, Health Care +2

General Information

Company Name Amicogen, Inc.
Founded Year 2000
Employees 21
Industries Biotechnology, Health Care, Nutrition +1
Funding Stage Post-IPO Equity
Social

BounceWatch is an independent company data service, not affiliated with Amicogen, Inc.. To contact Amicogen, Inc., visit amicogen.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Amicogen, Inc. compare?

A PDF of Amicogen, Inc. and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Amicogen, Inc. soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Amicogen, Inc.

Amicogen, Inc. is a South Korea-based company that operates in the biotechnology, health care, nutrition, and pharmaceutical industries. The company was founded in 2000 and has recently attracted a significant Post-IPO Equity investment on 01 January 2022.

The investment came from Company K Partners and Hyundai Venture Investment Corporation, signifying the confidence that these prominent investors have in Amicogen's potential for growth and innovation.

This recent investment marks a pivotal moment for Amicogen as it continues to make waves in the fields of biotechnology, health care, nutrition, and pharmaceuticals.

Business keywords: south korea, pharmaceuticals, biopharmaceuticals, biotech, innovation, biomedical, life sciences

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Post IPO Equity Undisclosed 2
Company K Partners, Hyundai Venture Investment Corporation
01 Jan 2022
Post IPO Equity KRW6.00B 2
Kibo Ventures, Aju IB Investment
10 Nov 2013

Amicogen, Inc. Alternatives & Competitors

Amicogen, Inc. vs
ARNAV Biotech
ARNAV Biotech United States

mRNA for all!

5 employees
Biotechnology, Health Care
Amicogen, Inc. vs

A New Generation Biotech Company

Grant
8 employees
Biotechnology, Health Care
Amicogen, Inc. vs

Bridging Life and Science with Innovative Linker Technology

Series B
11 employees
Biotechnology, Health Care

FAQ About Amicogen, Inc.

Amicogen Inc is a company based in South Korea.
Amicogen, Inc. was founded in 2000.
Amicogen, Inc. operates in Biotechnology, Health Care, Nutrition and Pharmaceutical. Its work centres on south korea, pharmaceuticals, biopharmaceuticals and biotech.
Amicogen, Inc. has approximately 21 employees.
Amicogen, Inc. has completed 2 funding rounds, raising a total of $6.00B. The latest funding stage is Post-IPO Equity.
Top alternatives and competitors to Amicogen, Inc. include ARNAV Biotech, ABIONYX Pharma, AbTis | 앱티스, Nouscom , Arctic Vision Ltd.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Amicogen, Inc. and ARNAV Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Amicogen, Inc., https://bouncewatch.com/company/amicogen-inc, updated 28 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes